') no-repeat 50% 50%;mask:url('data:image/svg+xml,') no-repeat 50% 50%;-webkit-mask-size:cover;mask-size:cover;margin-left:.625rem;transform:rotate(0);transition:transform .1s}.dropdown-toggle:not([class*=btn-]):focus,.dropdown-toggle:not([class*=btn-]):hover{color:#2196f3;font-weight:500;background-color:inherit}.form-control{height:calc(1.6568em + 1.25rem + 2px);background-clip:border-box;-webkit-appearance:none;filter:none}.form-control:-webkit-autofill,.form-control:-webkit-autofill:active,.form-control:-webkit-autofill:focus,.form-control:-webkit-autofill:hover{box-shadow:0 0 0 30px #fff inset!important}.form-control:disabled{color:#999;background-color:#f5f5f5}.form-control,.form-control:focus,.form-control:focus-visible{box-shadow:none}.input-group-sm .form-control{height:2.10419375rem}.form-check-new{position:relative;display:flex}.form-check-new+.form-check-new{margin-top:.625rem}.form-check-new:not(.inline){margin-bottom:.25rem}.form-check-new:not(.inline)>xetf-checkbox{margin-right:.875rem}.text-check{line-height:1.5;font-size:.75rem;color:#444;padding-top:1px}.text-check.sm{font-size:.625rem;padding-top:2px}.text-check a{font-weight:600}.check-container{display:flex;align-items:center;margin-bottom:0;cursor:pointer}.check-container:not(.disabled):hover{color:#666}.check-container .checkbox,.check-container .checkbox input,.check-container .checkbox span{width:var(--checkbox-size);height:var(--checkbox-size)}.check-container .checkbox input{border:0;background:0 0;display:inline-block;margin:0;cursor:pointer;position:absolute;visibility:visible;opacity:0;z-index:2}.check-container .checkbox input:checked~span:after{opacity:1}.check-container .checkbox input:focus~span,.check-container .checkbox input:hover~span{box-shadow:0 4px 4px #0000001f}.check-container .checkbox span{display:inline-block;position:relative;text-align:center;border-style:solid;border-color:#999;color:#42a5f5;transition:box-shadow .15s ease-in}.check-container .checkbox span:after{content:"";position:absolute;opacity:0;transition:opacity .15s ease-in}.check-container .checkbox span:checked:after{opacity:1}.fs-sm{font-size:.8125rem!important}.fs-larger{font-size:larger}.w-75{width:75%!important}.w-100{width:100%!important}.hidden{visibility:hidden}.nowrap{white-space:nowrap}.bg-grey-light{background-color:#e5e5e5}.input-group{margin-bottom:1.25rem}.input-group .form-control::placeholder{color:#aaa;font-weight:500}.input-group .form-control::-webkit-search-cancel-button{display:none}.input-group .form-control::-webkit-inner-spin-button,.input-group .form-control::-webkit-outer-spin-button{-webkit-appearance:none;margin:0}.input-group:focus-within .input-group-text{border-color:#999}.input-group-text{font-weight:500;transition:border-color .15s ease-in-out,box-shadow .15s ease-in-out}.input-group-text xetf-icon{color:#bbb;font-size:.9375rem;z-index:4}.input-group-text:first-child{border-right:0;border-top-right-radius:0;border-bottom-right-radius:0}.input-group-text+.form-control{border-left:0}.input-group-text+.form-control{padding-left:0}.input-group-text+.form-control:disabled{border-left-width:0;padding-left:2.625rem!important;margin-left:-2.625rem!important}html{display:flex;flex-direction:column;scroll-behavior:smooth}body{min-height:100vh;display:flex;flex-direction:column;flex:1}.content{padding:1.25rem .625rem;flex-grow:1;z-index:1}.container{padding-left:0;padding-right:0}@media (max-width:991.98px){.container{max-width:100%}}app-root{transition:.15s ease-in}.nav-link{position:relative;transition:.15s ease-in-out}.nav-pills{margin-bottom:1.25rem}.nav-pills .nav-link{color:#777}.nav-pills .nav-link:not(.active):focus,.nav-pills .nav-link:not(.active):hover{color:#324148}.toolbar-container{display:flex;flex-wrap:wrap;position:relative}.toolbar-container .toolbar-main-items,.toolbar-container .toolbar-misc-items{height:40px}.toolbar-container .toolbar-main-items{position:static;overflow-x:auto;overflow-y:hidden;flex:1 0 100%}.toolbar-container .toolbar-main-items:after,.toolbar-container .toolbar-main-items:before{content:"";position:absolute;top:0;width:30px;height:40px;z-index:1;transition:box-shadow .3s;pointer-events:none}.toolbar-container .toolbar-main-items:before{left:0}.toolbar-container .toolbar-main-items:after{right:0}.toolbar-container .toolbar-main-items::-webkit-scrollbar{display:none}.toolbar-container .toolbar-misc-items{position:relative;display:flex;flex-wrap:nowrap;flex-grow:1}.toolbar-container .border-placeholder{position:absolute;left:0;right:0;top:38px;height:2px;background-color:#e5e5e5}.toolbar-container .nav-pills{justify-content:space-between;flex-wrap:nowrap;margin-bottom:0}.toolbar-container .nav-pills>:not(.separator){text-align:center;flex:1}.toolbar-container .separator{position:relative}.toolbar-container .separator:after{content:"";position:absolute;height:14px;width:1px;right:1px;border-right:1px solid #c9c9c9;top:calc(50% - 7px)}.toolbar-container .nav-link{position:relative;white-space:nowrap;-webkit-user-select:none;user-select:none;line-height:20px;padding:10px 20px;color:#333;border-radius:0}.toolbar-container .nav-link:focus,.toolbar-container .nav-link:hover{color:#2196f3!important}.toolbar-container .nav-link.active{color:#2196f3!important;background-color:transparent!important}.toolbar-container .nav-link.active:after{content:"";position:absolute;bottom:0;left:0;right:0;height:4px;background-color:#2196f3;z-index:2}.navbar{font-size:.75rem;font-weight:600}.navbar .dropdown-menu,.navbar .navbar-nav-link{font-size:.75rem;white-space:nowrap}.navbar .nav-item>a{border-bottom:2px solid transparent}.navbar-brand img{height:1.625rem;display:block}@media (max-width:1199.98px){.navbar-brand img{height:1.25rem}}.navbar-nav{justify-content:space-evenly}.navbar-nav-link{position:relative;display:flex;cursor:pointer;padding:1rem;outline:0;transition:.15s ease-in-out}.navbar-toggler{border:0;cursor:pointer;padding-left:0;padding-right:0;transition:.15s ease-in-out}@media (max-width:1199.98px){.navbar-toggler{padding-top:.75rem;padding-bottom:.75rem}.navbar-expand-xl .navbar-nav-link{display:flex;align-items:center;margin-left:-1.5rem;margin-right:-1.5rem;padding-left:1.5rem;padding-right:1.5rem}}.navbar-dark{color:#fff;background-color:#324148}.navbar-dark .navbar-nav-link{color:#fff}.navbar-dark .navbar-nav-link:focus,.navbar-dark .navbar-nav-link:hover{color:#fff;background-color:#00000026}.table{margin-bottom:0;color:#324148}.table td,.table th{vertical-align:middle;padding-left:2px;padding-right:2px}.table th{font-weight:500}.table thead th{vertical-align:middle;border-bottom:2px solid #e5e5e5}.table>:not(:first-child){border-top:0}.table tbody tr:last-child>*{border-bottom-width:0}.table.last-column-end td:last-child,.table.last-column-end th:last-child{text-align:right}h1,h2,h3{letter-spacing:-.015em}.text-default{color:#324148!important}a.text-default:not(.btn):not(.td_btn):not(.vc_btn){transition:color .15s ease-in-out}a.text-default:focus,a.text-default:hover{color:#324148bf}.profile-card h1{font-size:1.875rem;font-weight:700;margin-bottom:0;line-height:1}@media (max-width:767.98px){.profile-card{margin-bottom:1rem}.profile-card h1{font-size:1.25rem}}.profile-card .card-body{padding-bottom:0}.profile-card .profile-main-info{font-size:.625rem;flex-wrap:wrap;align-items:center}.profile-card .profile-main-info.with-bottom-space>*{margin-bottom:1.125rem}.profile-card .profile-main-info .badge{display:inline-block!important;font-size:.625rem}.profile-card .profile-main-info .badge xetf-icon{font-size:10px}.profile-card .profile-main-info .badge.badge-light{padding-top:6px;padding-bottom:6px}.profile-card .separated-properties>span:not(:first-of-type):not(:empty):not(.badge):before{content:"|";color:#c9c9c9;font-size:1rem;margin-left:.25rem;margin-right:.25rem}.profile-card .separated-properties>a.badge:not(:last-child),.profile-card .separated-properties>span.badge:not(:last-child){margin-right:.625rem!important}.profile-card .nav-pills{margin-bottom:1.125rem}.profile-card .top-info{display:flex;flex-wrap:wrap;min-width:150px}@media (max-width:767.98px){.profile-card .top-info.desktop-only{display:none}}.profile-card .top-info .top-info-column{position:relative;margin-bottom:1.125rem}.profile-card .top-info .top-info-column>.text-muted{display:flex;align-items:center;white-space:nowrap}.profile-card .top-info .top-info-column:not(:last-child){padding-right:1.25rem;margin-right:1.25rem}.profile-card .top-info .top-info-column:not(:last-child):after{content:"";position:absolute;height:14px;width:1px;right:1px;border-right:1px solid #c9c9c9;top:calc(50% - 7px);padding:0 1.25rem}.profile-card .top-info .value{font-size:.875rem;line-height:130%;font-weight:700}.profile-card .top-info .text-muted{font-size:.625rem}.profile-card .top-info .text-muted>xetf-icon{margin-left:.3125rem;color:#1976d2}.profile-card .provider-icon-wrapper{display:flex;align-items:flex-start;margin-bottom:.625rem}.profile-card .provider-icon-wrapper .provider-logo{display:block;height:50px;width:50px;margin:0 1.25rem auto 0;overflow:hidden}.profile-card .provider-icon-wrapper .investment-name-wrapper{display:flex;flex-direction:column}.profile-card .provider-icon-wrapper .investment-name-wrapper .investment-name{display:flex;flex-direction:row}.profile-card .provider-icon-wrapper .investment-name-wrapper xetf-icon{color:#1976d2}.profile-card .toolbar-container{border-top:2px solid #e5e5e5}.profile-card .toolbar-container .toolbar-main-items{border-bottom-left-radius:5px}.profile-card .toolbar-container.with-misc-items .toolbar-main-items .nav-item .nav-link{padding-left:14px;padding-right:14px}@media (max-width:767.98px){.profile-card .toolbar-container.with-misc-items .toolbar-main-items .nav-item .nav-link{min-width:calc((100vw - 1.25rem)/ 3)}}.profile-card .toolbar-container.with-misc-items .toolbar-misc-items{justify-content:space-evenly}.profile-card .toolbar-container.with-misc-items .toolbar-misc-items>:not(.separator){padding-left:2rem;padding-right:2rem}.profile-card .toolbar-container.with-misc-items .toolbar-misc-items xetf-icon{display:block}.profile-card .border-placeholder{display:none}h1,h2,h3{font-weight:700}.app-container{width:100%;margin:0 auto}a{cursor:pointer}.auth-offer-container{position:relative;display:block;min-height:150px}.tp-change-label{font-weight:700;padding:2px 20px 2px 7px;border-radius:6px;display:inline-block;white-space:nowrap;position:relative}.tp-change-label.arrow:after{content:"";-webkit-mask:url('data:image/svg+xml,') no-repeat 50% 50%;mask:url('data:image/svg+xml,') no-repeat 50% 50%;-webkit-mask-size:cover;mask-size:cover;display:inline-block;background-color:currentColor;width:10px;height:5px;margin-left:4px;position:absolute;right:5px;bottom:calc(50% - 2.5px)}.tp-change-label.arrow.down:after{transform:rotate(180deg)}.tp-change-label.plus{background-color:#cdf6c3;color:#388e3c}.tp-change-label.minus{background-color:#f8e2e0;color:#a42330}.real-time-course-wrapper{display:flex;align-items:center;justify-content:space-between;flex-wrap:wrap}.course-value{font-size:1.625rem;font-weight:700;margin-bottom:0;margin-right:1.5rem}.course-percentage{font-size:1rem;font-weight:700}.card-columns-ordered>*{page-break-inside:avoid!important;break-inside:avoid!important}.perf-period-pa{min-width:92px;white-space:nowrap}.table-cell-inline{display:inline-flex;width:100%}.table-cell-inline span:first-of-type{min-width:80px;text-align:right}
Der Invesco NASDAQ Biotech UCITS ETF ist bei insgesamt 9 Online Broker(n) sparplanfähig. Bei 5 Anbieter(n) davon ist der ETF aktuell kostenfrei im Sparplan erhältlich. Die Mindestsparrate beträgt 1 €. Der ETF ist VL-fähig.
Wichtige Stammdaten zum Invesco NASDAQ Biotech UCITS ETF
Gesamtkostenquote (TER) | 0,40 % |
Indexabbildung | Synthetisch |
Abbildungsart | Unfunded |
Ertragsverwendung | Thesaurierend |
Fondsgröße | 631,82 Mio. € |
Fondsauflage | 06.11.2014 |
Fondswährung | USD |
Währungsabsicherung | Nein |
Fondsdomizil | Irland |
Indexname | NASDAQ Biotechnology TR USD (1) |
Enthaltene Werte | 1 |
Aktienpositionen | 0 |
Anleihenpositionen | 0 |
Cash und sonstige Positionen | 1 |
Hier findest du alternative Indexfonds zum NASDAQ Biotechnology TR USD.
Fondsname | WKN | TER |
---|---|---|
Keine Ergebnisse |
Der Invesco NASDAQ Biotech UCITS ETF ermöglicht Anlegern, in aufstrebende Biotechnologie- und Pharmatitel mit Listing am NASDAQ Stock Market zu investieren. Der NASDAQ Biotechnologie Index ist nach Marktkapitalisierung gewichtet und enthält 116 Komponenten, die nach der Industry Classification Benchmark (ICB) als Biotechnologie- oder Pharmaunternehmen eingestuft werden.
Hier siehst du die Wertentwicklung (inkl. Ausschüttung) des Invesco NASDAQ Biotech UCITS ETF.
Zeitraum | Performance |
---|---|
1 Woche | +3,03 % |
1 Monat | +2,82 % |
3 Monate | +22,80 % |
6 Monate | +13,08 % |
1 Jahr | -10,80 % |
3 Jahre | +39,23 %(11,66 % p.a.) |
5 Jahre | +52,10 %(8,75 % p.a.) |
10 Jahre | — |
Seit Auflage | +113,99 %(10,30 % p.a.) |
Jahr | Performance |
---|---|
Lfd. Jahr | -1,54 % |
2021 | +7,19 % |
2020 | +15,52 % |
2019 | +26,91 % |
2018 | -4,65 % |
2017 | +6,42 % |
Stand: 10.08.2022. Performance angezeigt in EUR.
Wichtige Risiko- und Analysekennzahlen zum Invesco NASDAQ Biotech UCITS ETF
Volatilität | 17,43 %1 Jahr 19,53 %3 Jahre 19,75 %5 Jahre |
max. Drawdown | -30,36 %1 Jahr -30,36 %3 Jahre -30,36 %5 Jahre |
Sharpe Ratio | -1,431 Jahr 0,353 Jahre 0,215 Jahre |
XLM | 24,79 |
Stammdaten werden bereitgestellt von Morningstar (Aktien, ETFs, Fonds), CoinGecko (Kryptowährungen) und der Isarvest GmbH. Kursdaten sind mindestens 15 Minuten zeitverzögerte Börsenkurse (Aktien, ETFs, Fonds) oder NAV-Kurse (ETFs, Fonds). Realtime-Kurse – sofern verfügbar – stammen von den Anbietern und der Lang & Schwarz (Aktien, ETFs, Fonds) und CoinGecko (Kryptowährungen).
Die Isarvest GmbH übernimmt für die dargestellten Informationen keine Gewährleistung und kann nicht sicherstellen, dass die Daten vollständig und genau sind.